Key statistics
On Tuesday, NextCure Inc (2US:BER) closed at 1.27, 32.78% above the 52 week low of 0.958 set on Oct 31, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.23 |
---|---|
High | 1.27 |
Low | 1.23 |
Bid | -- |
Offer | -- |
Previous close | 1.27 |
Average volume | 723.50 |
---|---|
Shares outstanding | 27.98m |
Free float | 25.49m |
P/E (TTM) | -- |
Market cap | 37.77m USD |
EPS (TTM) | -2.20 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 20:52 BST.
More ▼
Announcements
- NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting
- NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024
- NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results
- NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
- NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
- NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
- NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
- NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
- NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
- NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
More ▼